+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Physical chemical drug-drug interactions from drug discovery to registration: new opportunities for the pharmaceutical scientist to impact drug development



Physical chemical drug-drug interactions from drug discovery to registration: new opportunities for the pharmaceutical scientist to impact drug development



Molecular Pharmaceutics 10(11): 3967-3969




(PDF emailed within 0-6 h: $19.90)

Accession: 054994537

Download citation: RISBibTeXText

PMID: 24491029

DOI: 10.1021/mp4005639


Related references

Evaluation of the use of static and dynamic models to predict drug-drug interaction and its associated variability: impact on drug discovery and early development. Drug Metabolism and Disposition: the Biological Fate of Chemicals 40(8): 1495-1507, 2012

Introduction to in vitro estimation of metabolic stability and drug interactions of new chemical entities in drug discovery and development. Pharmacological Reports 58(4): 453-472, 2006

Prediction of ARA/PPI Drug-Drug Interactions at the Drug Discovery and Development Interface. Journal of Pharmaceutical Sciences 2018, 2018

Impact of the drug-drug interaction database SFINX on prevalence of potentially serious drug-drug interactions in primary health care. European Journal of Clinical Pharmacology 69(3): 565-571, 2013

Impact of Drug Treatment at Neonatal Ages on Variability of Drug Metabolism and Drug-drug Interactions in Adult Life. Current Pharmacology Reports 3(1): 1-9, 2017

Development of an ADME and drug-drug interactions knowledge database for the acceleration of drug discovery and development. Expert Opinion on Drug Discovery 1(7): 737-751, 2006

In vitro human hepatocyte-based experimental systems for the evaluation of human drug metabolism, drug-drug interactions, and drug toxicity in drug development. Current Topics in Medicinal Chemistry 14(11): 1325-1338, 2015

Risk of Drug-Drug Interactions in Out-Hospital Drug Dispensings in France: Results From the DRUG-Drug Interaction Prevalence Study. Frontiers in Pharmacology 10: 265, 2019

Herb-drug, food-drug, nutrient-drug, and drug-drug interactions: mechanisms involved and their medical implications. Journal of Alternative and Complementary Medicine 8(3): 293-308, 2002

Drug-drug interactions of anti-infective drugs: utility of fluorescence cyp inhibition assays in drug discovery. Drug Metabolism and Drug Interactions 21(3-4): 163-185, 2006

Risk assessment of drug-drug interactions using hepatocytes suspended in serum during the drug discovery process. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 44(4): 336-344, 2014

Predicting human hepatic clearance from in vitro drug metabolism and transport data: a scientific and pharmaceutical perspective for assessing drug-drug interactions. Biopharmaceutics and Drug Disposition 33(4): 179-194, 2012

A simplified approach to predict CYP3A-mediated drug-drug interactions at early drug discovery: validation with clinical data. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 43(7): 592-597, 2014

Challenges and opportunities with modelling and simulation in drug discovery and drug development. Xenobiotica; the Fate of Foreign Compounds in Biological Systems 37(10-11): 1295-1310, 2007

Barriers to Alzheimer disease drug discovery and drug development in the pharmaceutical industry. Alzheimer Disease and Associated Disorders 16 Suppl 1: S33-S39, 2002